Core Operating Income: JPY140.5 billion, an improvement of JPY289.6 billion year-on-year. Sales Revenue: JPY2.663 trillion, an increase of JPY159.4 billion year-on-year. Net Income Attributable to Owners: JPY38.6 billion, a JPY350.4 billion improvement from the previous year. Operating Income: JPY193.0 billion, a significant improvement of JPY681.9 billion from the previous year. Finance Expenses: JPY134.9 billion, a deterioration of JPY161.0 billion from the previous fiscal year. Income Tax Expense: JPY15.4 billion, an increase of JPY12.7 billion from the previous year. ROIC: 2.2%, a significant improvement year-on-year. Total Assets: JPY3.438 trillion, a decrease of JPY495.0 billion from the end of the previous period. Interest-Bearing Debt: JPY1.2861 trillion, a decrease of JPY277.4 billion from the end of the previous fiscal year. Cash Flow from Operating Activities: Positive JPY233.0 billion, an increase of JPY284.3 billion from the previous year. Free Cash Flow: Positive JPY318.3 billion, a JPY481.8 billion improvement from the previous fiscal year. Dividend Forecast: Annual dividend of JPY12 per share, an increase of JPY3 compared to the previous fiscal year.

Warning! GuruFocus has detected 4 Warning Signs with SOMMF. High Yield Dividend Stocks in Gurus' Portfolio This Powerful Chart Made Peter Lynch 29% A Year For 13 Years How to calculate the intrinsic value of a stock?

Release Date: May 14, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Sumitomo Chemical Co Ltd (SOMMF) achieved a V-shaped recovery in fiscal 2024 with a core operating income of JPY140.5 billion, a significant improvement from the previous year's loss. Sales revenue increased by JPY159.4 billion year-on-year, with all segments reporting revenue growth. The company recorded a total gain of JPY52.5 billion on nonrecurring items, showing a substantial improvement from the previous fiscal year's losses. Free cash flow improved significantly to JPY318.3 billion, a JPY481.8 billion improvement from the previous fiscal year. Sumitomo Chemical Co Ltd (SOMMF) plans to increase its dividend to JPY12 per share, reflecting confidence in its financial stability and commitment to shareholder returns.

Negative Points

ROIC was reported at 2.2%, which is still considered unsatisfactory despite the year-on-year improvement. Finance expenses increased by JPY161.0 billion from the previous fiscal year, primarily due to losses related to the waiver of loans to Petro Rabigh. The company expects a decrease in sales revenue by JPY266.3 billion in fiscal 2025, with all segments projected to see a decline. The business environment is facing increasing downside risks due to global economic uncertainties and trade frictions. The impact of the US tariff policy and stronger yen are expected to negatively affect core operating income in fiscal 2025.

Story Continues

Q & A Highlights

Q: Could you explain the impact of exchange rates and the U.S. tariff policy on your financial results? A: The exchange rate assumption was revised from JPY150 to JPY145 to the dollar, impacting core operating income by approximately JPY20 billion. The U.S. tariff policy had a direct impact on costs and an indirect impact on the supply chain, with an estimated JPY10 billion effect on core operating income. (Keigo Sasaki, Managing Executive Officer)

Q: How does the reduction in equity stake in Petro Rabigh affect your financials? A: The reduction in equity stake is expected to decrease equity method losses by about JPY40 billion. The sale of the 22.5% stake is delayed due to regulatory negotiations in Saudi Arabia, but we anticipate realizing this in the near future. (Keigo Sasaki, Managing Executive Officer)

Q: What are the expectations for the ICT & Mobility Solutions segment, particularly regarding shipment volumes and market recovery? A: We expect growth in mid- to small-sized displays, especially for OLEDs in smartphones, and a gradual recovery in semiconductor materials. The segment is impacted by exchange rates and tariffs, but we anticipate steady growth in 2025. (Keigo Sasaki, Managing Executive Officer)

Q: Can you elaborate on the Agro & Life Solutions segment's performance and future outlook? A: We expect solid growth in products like INDIFLIN, especially in Brazil and India. The segment's revenue was lower than projected, but profit exceeded expectations due to a favorable product mix and reduced unprofitable methionine sales. (Keigo Sasaki, Managing Executive Officer)

Q: What is the rationale behind the dividend increase despite ongoing restructuring efforts? A: The dividend increase reflects our commitment to shareholders and confidence in our financial stability. We aim to complete major restructuring activities in FY 2025, incorporating risks into our plans to minimize future nonrecurring items. (Keigo Sasaki, Managing Executive Officer)

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

View Comments